JP2021515558A5 - - Google Patents
Info
- Publication number
- JP2021515558A5 JP2021515558A5 JP2020546854A JP2020546854A JP2021515558A5 JP 2021515558 A5 JP2021515558 A5 JP 2021515558A5 JP 2020546854 A JP2020546854 A JP 2020546854A JP 2020546854 A JP2020546854 A JP 2020546854A JP 2021515558 A5 JP2021515558 A5 JP 2021515558A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- region
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023172758A JP2023168545A (ja) | 2018-03-09 | 2023-10-04 | 二量体抗原受容体(dar) |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862640775P | 2018-03-09 | 2018-03-09 | |
| US62/640,775 | 2018-03-09 | ||
| PCT/US2019/021681 WO2019173837A1 (en) | 2018-03-09 | 2019-03-11 | Dimeric antigen receptors (dar) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172758A Division JP2023168545A (ja) | 2018-03-09 | 2023-10-04 | 二量体抗原受容体(dar) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021515558A JP2021515558A (ja) | 2021-06-24 |
| JP2021515558A5 true JP2021515558A5 (cg-RX-API-DMAC7.html) | 2022-03-04 |
| JP7542439B2 JP7542439B2 (ja) | 2024-08-30 |
Family
ID=67846344
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546854A Active JP7542439B2 (ja) | 2018-03-09 | 2019-03-11 | 二量体抗原受容体(dar) |
| JP2023172758A Pending JP2023168545A (ja) | 2018-03-09 | 2023-10-04 | 二量体抗原受容体(dar) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172758A Pending JP2023168545A (ja) | 2018-03-09 | 2023-10-04 | 二量体抗原受容体(dar) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12180294B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3762430A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7542439B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200130395A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112105649B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019231315A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3092993A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL277181A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202008568WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019173837A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200076732A (ko) * | 2017-11-03 | 2020-06-29 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Cd38-지시된 키메라 항원 수용체 작제물 |
| JP7637510B2 (ja) * | 2018-06-20 | 2025-02-28 | ビバソル, インコーポレイテッド | Cd38に結合するバリアント抗体 |
| EP3938510A1 (en) | 2019-03-11 | 2022-01-19 | Sorrento Therapeutics, Inc. | Improved process for integration of dna constructs using rna-guided endonucleases |
| CN114650829A (zh) * | 2019-09-05 | 2022-06-21 | 索伦托药业有限公司 | 结合bcma的二聚体抗原受体(dar) |
| JP2023516595A (ja) * | 2020-02-27 | 2023-04-20 | ソレント・セラピューティクス・インコーポレイテッド | Cd20を結合する二量体抗原受容体(dar) |
| EP4139345A1 (en) | 2020-04-24 | 2023-03-01 | Sorrento Therapeutics, Inc. | Memory dimeric antigen receptors |
| WO2022015956A1 (en) | 2020-07-15 | 2022-01-20 | Sorrento Therapeutics, Inc. | Improved process for dna integration using rna-guided endonucleases |
| KR102598598B1 (ko) | 2020-10-08 | 2023-11-07 | 엘티소재주식회사 | 헤테로고리 화합물, 이를 포함하는 유기 발광 소자, 이의 제조 방법 및 유기 발광 소자의 유기물층용 조성물 |
| CN116601174A (zh) * | 2020-10-12 | 2023-08-15 | 索伦托药业有限公司 | Cd19定向的嵌合抗原受体构建体 |
| IL305175A (en) * | 2021-02-19 | 2023-10-01 | Angeles Therapeutics Inc | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells |
| CN112662631B (zh) * | 2021-03-16 | 2021-06-29 | 合源生物科技(天津)有限公司 | 一种car-t细胞灌流培养方法 |
| US20240197881A1 (en) * | 2021-04-23 | 2024-06-20 | Sorrento Therapeutics, Inc. | Dimeric Antigen Receptors (DARs) that Bind GD2 |
| EP4453018A1 (en) * | 2021-12-24 | 2024-10-30 | ETH Zurich | Multichain antigen-specific receptors for cell-based immunotherapy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| US9708384B2 (en) * | 2011-09-22 | 2017-07-18 | The Trustees Of The University Of Pennsylvania | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens |
| CN113527495A (zh) * | 2015-04-08 | 2021-10-22 | 索伦托药业有限公司 | 与cd38结合的抗体治疗剂 |
| US10471098B2 (en) * | 2015-04-15 | 2019-11-12 | Prospect Chartercare Rwmc, Llc | Hepatic arterial infusion of CAR-T cells |
| CN107849102B (zh) | 2015-05-15 | 2022-05-13 | 希望之城 | 嵌合抗原受体组合物 |
| MX2018004721A (es) * | 2015-10-23 | 2018-07-06 | Eureka Therapeutics Inc | Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas. |
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| US11291721B2 (en) * | 2016-03-21 | 2022-04-05 | Marengo Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| WO2018075813A1 (en) * | 2016-10-19 | 2018-04-26 | City Of Hope | Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy |
| KR20200076732A (ko) | 2017-11-03 | 2020-06-29 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Cd38-지시된 키메라 항원 수용체 작제물 |
| EP3729081B1 (en) | 2017-12-21 | 2025-02-19 | F. Hoffmann-La Roche AG | Car-t cell assay for specificity test of novel antigen binding moieties |
| WO2019192973A1 (en) | 2018-04-04 | 2019-10-10 | F. Hoffmann-La Roche Ag | Diagnostic assays to detect tumor antigens in cancer patients |
| JP2021520209A (ja) | 2018-04-04 | 2021-08-19 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 癌患者における腫瘍抗原を検出するための診断アッセイ |
-
2019
- 2019-03-11 SG SG11202008568WA patent/SG11202008568WA/en unknown
- 2019-03-11 KR KR1020207028896A patent/KR20200130395A/ko not_active Ceased
- 2019-03-11 EP EP19764893.4A patent/EP3762430A4/en not_active Withdrawn
- 2019-03-11 CA CA3092993A patent/CA3092993A1/en active Pending
- 2019-03-11 CN CN201980031146.3A patent/CN112105649B/zh active Active
- 2019-03-11 JP JP2020546854A patent/JP7542439B2/ja active Active
- 2019-03-11 AU AU2019231315A patent/AU2019231315A1/en not_active Abandoned
- 2019-03-11 WO PCT/US2019/021681 patent/WO2019173837A1/en not_active Ceased
-
2020
- 2020-09-04 US US17/013,359 patent/US12180294B2/en active Active
- 2020-09-07 IL IL277181A patent/IL277181A/en unknown
-
2023
- 2023-10-04 JP JP2023172758A patent/JP2023168545A/ja active Pending